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18F-fluorodeoxyglucose (FDG) positron emission tomog-
raphy (PET) imaging is strongly recommended in patients
with diffuse large B-cell lymphomas (DLBCL), which are
routinely highly FDG avid, for adequate disease staging
[1]. The mean standardized uptake value (SUV) can be
used to distinguish aggressive from indolent lymphoma
variants [2]. PET scanning is a reliable method for the
diagnosis of DLBCL compared with the reference method
immunohistology [3].
We present a case of a 70-year-old female patient who
presented to the hospital with progressive swelling, pain
and loss of sensibility in her right lower limb. Nine months
earlier she had been diagnosed with DLBLC, localized in
the lungs, mediastinum and mesenterium for which she was
treated with rituximab plus cyclophosphamide, doxorubi-
cin, vincristine and prednisone (R-CHOP) chemotherapy.
18F-FDG PET/CT scanning was performed for restaging of
lymphoma disease in this patient.
18F-FDG PET/CT showed an extensive lesion in the
right lower limb, with extremely high avidity for FDG,
corresponding with tumour mass in muscular tissue on the
low-dose CT (figure). It was spreading upwards, following
the lymphatic drainage system and surrounding vessels, up
to the right groin region. The SUVmean of this large lesion
was 16.4 (calculation conforming to the EANM procedure
guidelines for tumour PET imaging [4]). Further on, a
lesion was detected dorsally in the right lung.
Biopsy of the swelling in the right lower limb revealed
aggressive DLBCL recurrence. This aggressive form was
already expected due to the high SUVmean value. This scan
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shows how aggressive DLBCL can appear as a fast
growing lymphoma with an atypical configuration by
following the lymphatic drainage.
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